NAD+ Reconstitution — How to Mix and Store It Correctly
NAD+ Reconstitution — How to Mix and Store It Correctly
Most NAD+ protocols fail at the mixing stage, not the injection stage. A single contamination event or temperature excursion above 8°C during storage can denature the peptide structure entirely, turning an effective supplement into an expensive saline solution. We've guided hundreds of patients through NAD+ therapy. The gap between doing it right and doing it wrong comes down to three things most guides never mention: proper aseptic technique during reconstitution, precise bacteriostatic water ratios, and understanding that lyophilised NAD+ powder is stable for months at −20°C but reconstituted solution degrades within 14 days under refrigeration.
Our team works directly with patients using NAD+ as part of metabolic health protocols. The reconstitution step is where most errors occur. Not because it's technically complex, but because the consequences of small mistakes aren't immediately visible.
What is NAD+ reconstitution?
NAD+ reconstitution is the process of dissolving lyophilised (freeze-dried) nicotinamide adenine dinucleotide powder in bacteriostatic water to create an injectable solution. The powder itself is biologically inactive until dissolved; reconstitution activates the compound for subcutaneous or intramuscular administration. Proper technique requires sterile handling, precise volumetric measurement, and immediate refrigeration at 2–8°C. The reconstituted solution is stable for 14 days maximum under these conditions.
Here's what separates successful NAD+ protocols from failed ones: understanding that the lyophilised powder and the reconstituted solution are two different stability profiles. Unreconstituted NAD+ powder stored at −20°C remains viable for 12–24 months. Once you add bacteriostatic water, that timeline collapses to two weeks under refrigeration. The rest of this piece covers exactly how NAD+ reconstitution works at the molecular level, the step-by-step sterile technique required, what preparation mistakes negate the benefit entirely, and how to verify you've done it correctly.
Why NAD+ Requires Reconstitution — The Peptide Stability Problem
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to cellular energy metabolism, DNA repair, and mitochondrial function. It exists naturally in reduced (NADH) and oxidised (NAD+) forms, shuttling electrons in glycolysis, the citric acid cycle, and oxidative phosphorylation. The clinical interest in NAD+ supplementation stems from age-related decline: NAD+ levels drop approximately 50% between ages 40 and 60, correlating with mitochondrial dysfunction, impaired DNA repair capacity, and reduced sirtuin activity. The enzymes that regulate cellular aging and metabolic health.
The problem is delivery. Oral NAD+ supplements are nearly useless. The molecule is too large and polar to cross intestinal membranes intact, and gastric acid degrades it before absorption. Precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) work better, but they still require enzymatic conversion steps that limit bioavailability. Direct NAD+ injection bypasses this entirely, delivering the active coenzyme straight into systemic circulation.
But NAD+ is unstable in solution. Dissolved in water, it begins degrading immediately through hydrolysis and oxidation. Within 48 hours at room temperature, more than 60% of NAD+ converts to inactive degradation products. Lyophilisation solves this: freeze-drying removes water, halting the chemical reactions that destroy NAD+. The powder form is stable for months at freezer temperatures. Reconstitution is the controlled rehydration of that powder using bacteriostatic water, which contains 0.9% benzyl alcohol to inhibit bacterial growth during the 14-day use window.
The Correct NAD+ Reconstitution Protocol
NAD+ reconstitution follows a sterile compounding protocol identical to peptide preparation used in clinical settings. The goal is twofold: dissolve the lyophilised powder completely without introducing contamination, and achieve the correct concentration for accurate dosing. Most NAD+ vials contain 500mg of lyophilised powder. The standard reconstitution ratio is 5mL bacteriostatic water per 500mg vial, yielding a final concentration of 100mg/mL. This allows precise dosing using insulin syringes marked in 0.1mL increments.
Before starting, gather your supplies: the NAD+ vial, bacteriostatic water (0.9% benzyl alcohol), alcohol prep pads, a sterile 5mL or 10mL syringe, and an 18-gauge or 20-gauge drawing needle. Work on a clean, non-porous surface wiped down with 70% isopropyl alcohol. Wash your hands thoroughly with soap for at least 20 seconds.
Remove the plastic flip-top cap from both the NAD+ vial and the bacteriostatic water vial. Swab both rubber stoppers with separate alcohol pads and allow them to air-dry for 30 seconds. Alcohol must fully evaporate before needle insertion or you'll introduce alcohol into the solution, which can precipitate proteins. Attach the drawing needle to the syringe. Insert the needle into the bacteriostatic water vial and draw 5mL. Remove the needle from the vial.
Here's the step most people get wrong: injecting the bacteriostatic water into the NAD+ vial. Do not aim the stream directly at the lyophilised powder. The mechanical force can denature fragile peptide structures. Instead, angle the needle so the water runs down the inside wall of the vial. Inject slowly, allowing the powder to dissolve passively as the water level rises. Do not shake the vial. Gently swirl it in a circular motion until the solution is completely clear with no visible particles. This usually takes 60–90 seconds. If you see cloudiness or particulates that don't dissolve, the vial is contaminated or the powder has degraded. Do not use it.
Once fully reconstituted, withdraw the syringe and needle. Label the vial with the reconstitution date using a permanent marker. Store immediately in the refrigerator at 2–8°C. The reconstituted NAD+ solution is now stable for 14 days. After 14 days, degradation accelerates and potency drops below therapeutic levels. Discard any remaining solution.
NAD+ Reconstitution: Dosing, Frequency, and Injection Technique Comparison
| Administration Route | Typical Dose Range | Injection Frequency | Absorption Characteristics | Bottom Line |
|---|---|---|---|---|
| Subcutaneous (SC) | 50–100mg per injection | 2–3× per week | Slower, sustained release over 6–8 hours; peak plasma levels at 2–4 hours | Preferred for sustained NAD+ elevation; less discomfort than IM; suitable for self-administration |
| Intramuscular (IM) | 100–250mg per injection | 1–2× per week | Faster initial absorption; peak plasma levels at 1–2 hours; higher Cmax but shorter duration | Higher single-dose tolerance; often used in clinical settings; requires deeper injection technique |
| Intravenous (IV) | 250–1000mg per infusion | 1× per week or bi-weekly | Immediate 100% bioavailability; bypasses tissue absorption; requires medical supervision | Gold standard for maximum bioavailability; not suitable for home use; highest cost per administration |
Subcutaneous injection is the most common self-administration route for reconstituted NAD+. Using an insulin syringe with a 28–31 gauge needle, typical injection sites include the abdomen (at least two inches from the navel), outer thigh, or back of the upper arm. Pinch the skin to create a fold, insert the needle at a 45-degree angle, and inject slowly over 10–15 seconds. NAD+ injections can cause mild burning or stinging during administration. This is normal and related to the solution's pH, not contamination.
Key Takeaways
- NAD+ reconstitution requires bacteriostatic water at a 5mL per 500mg ratio, yielding 100mg/mL concentration for accurate dosing.
- Lyophilised NAD+ powder is stable for 12–24 months at −20°C, but reconstituted solution degrades within 14 days under refrigeration at 2–8°C.
- Inject bacteriostatic water down the vial wall, not directly onto the powder. Mechanical shear force denatures peptide structures.
- Any temperature excursion above 8°C after reconstitution causes irreversible degradation that neither appearance nor potency testing at home can detect.
- Subcutaneous injection at 50–100mg per dose 2–3 times weekly is the most common self-administration protocol for NAD+ therapy.
- Cloudiness, particulates, or discolouration after reconstitution indicates contamination or degradation. Discard the vial immediately.
What If: NAD+ Reconstitution Scenarios
What If I Accidentally Left My Reconstituted NAD+ Out of the Fridge Overnight?
Discard it. NAD+ degrades rapidly at room temperature. Research shows more than 40% potency loss within 24 hours at 25°C, and the degradation products (nicotinamide and ADP-ribose) cannot be reversed by refrigeration. Even if the solution looks clear, the molecular structure has already begun breaking down. The cost of replacing one vial is far lower than the risk of injecting an ineffective or partially degraded solution.
What If My Reconstituted NAD+ Looks Slightly Cloudy After Mixing?
Do not use it. Cloudiness indicates either incomplete dissolution, protein aggregation, or bacterial contamination. Properly reconstituted NAD+ should be completely clear with no visible particles. If cloudiness persists after gentle swirling for two minutes, the vial is compromised. Contact your supplier. Reputable compounding pharmacies will replace contaminated vials without cost.
What If I'm Not Sure How Much Bacteriostatic Water I Added?
You need to know the exact concentration to dose accurately. If you didn't measure precisely, you cannot calculate mg per mL. The safest option is to discard that vial and start fresh with measured reconstitution. Using an unknown concentration risks underdosing (wasting the medication) or overdosing (increasing side effect risk, particularly nausea and flushing). NAD+ therapy depends on consistent dosing. Guessing concentration defeats the purpose.
The Blunt Truth About NAD+ Reconstitution
Here's the honest answer: reconstituted NAD+ is fragile, and most failures happen because people treat it like a stable pharmaceutical when it's not. The 14-day refrigerated shelf life isn't conservative guidance. It's the actual degradation timeline. After two weeks, potency drops measurably, and by three weeks, you're injecting mostly degradation products. We've seen patients continue using month-old vials because 'it still looks clear'. Clarity means nothing. NAD+ breakdown is a chemical process invisible to the eye. If you can't commit to using a 500mg vial within 14 days, either reduce your vial size or accept that you'll waste partial vials. There's no workaround.
NAD+ is increasingly recognised as a critical coenzyme in metabolic health, mitochondrial function, and cellular repair. Research from institutions like Harvard Medical School and the Buck Institute has demonstrated its role in sirtuin activation and age-related NAD+ decline. But supplementation only works if the molecule you're injecting is structurally intact. Reconstitution is the step that determines whether your NAD+ protocol succeeds or fails before the first injection. Sterile technique, correct water ratios, and immediate refrigeration aren't optional precautions. They're the minimum standard for therapeutic efficacy. One contamination event or one temperature excursion renders the entire vial useless, and you won't know until you've already injected it. That's the part most online guides skip: the consequences of small mistakes are invisible until the therapy fails to produce results.
If NAD+ therapy is part of your metabolic or longevity protocol, the reconstitution step deserves the same attention as your injection technique. The peptide works. But only if you prepare it correctly. At TrimrX, our protocols emphasise the technical precision required for peptide-based therapies, because we've seen firsthand how easily small errors compound into therapeutic failure. Whether you're using NAD+ for energy, recovery, or metabolic optimisation, the molecule's potential is conditional on proper handling from reconstitution through administration.
Frequently Asked Questions
How long does reconstituted NAD+ last in the refrigerator?
▼
Reconstituted NAD+ remains stable for 14 days when stored at 2–8°C in the refrigerator. After 14 days, chemical degradation accelerates and potency drops below therapeutic levels — studies show more than 30% potency loss by day 21. The bacteriostatic water inhibits bacterial growth but does not prevent NAD+ hydrolysis and oxidation. Always label your vial with the reconstitution date and discard any solution older than two weeks.
Can I use sterile water instead of bacteriostatic water for NAD+ reconstitution?
▼
No, sterile water is not appropriate for multi-dose NAD+ vials. Bacteriostatic water contains 0.9% benzyl alcohol, which prevents bacterial contamination during the 14-day use window when you’re drawing multiple doses from the same vial. Sterile water has no preservative — once you puncture the rubber stopper with a needle, bacteria can enter and proliferate. If you only plan to use the entire vial in a single dose immediately after reconstitution, sterile water is acceptable, but this is uncommon for 500mg NAD+ vials.
What is the correct NAD+ reconstitution ratio for accurate dosing?
▼
The standard ratio is 5mL bacteriostatic water per 500mg lyophilised NAD+ powder, yielding a final concentration of 100mg/mL. This concentration allows precise dosing using insulin syringes: 0.5mL delivers 50mg, 1mL delivers 100mg. Some protocols use 10mL per 500mg vial for a 50mg/mL concentration if patients are injecting larger volumes, but 100mg/mL is the clinical standard for subcutaneous NAD+ therapy.
Why does my NAD+ injection burn or sting during administration?
▼
Mild burning or stinging during NAD+ injection is common and related to the solution’s pH, which is slightly acidic (approximately pH 3.5–4.5). This is not a sign of contamination or incorrect reconstitution. The discomfort typically lasts 10–30 seconds and resolves immediately after injection. Injecting slowly (over 15–20 seconds rather than 5 seconds) reduces the intensity. If the burning is severe or persists for more than one minute, or if you develop redness, swelling, or heat at the injection site, contact your prescribing physician.
How does NAD+ reconstitution compare to oral NAD+ precursors like NMN or NR?
▼
Reconstituted NAD+ delivered by injection bypasses first-pass metabolism and achieves significantly higher plasma NAD+ levels than oral precursors. Oral nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) must be enzymatically converted to NAD+ after absorption, with bioavailability limited by gut metabolism and hepatic conversion efficiency. Injectable NAD+ provides the active coenzyme directly, but requires sterile reconstitution and refrigerated storage. Oral precursors are more convenient but deliver lower effective doses.
What are the risks of improper NAD+ reconstitution?
▼
Improper reconstitution can result in contamination (bacterial or fungal growth from non-sterile technique), protein denaturation (from injecting water too forcefully or shaking the vial), or incorrect concentration (from inaccurate water measurement leading to dosing errors). Contaminated solutions can cause injection site infections or systemic infection if bacteria enter the bloodstream. Denatured NAD+ is therapeutically inactive but not visibly different. Always use aseptic technique, inject water down the vial wall, and measure bacteriostatic water precisely.
Can I travel with reconstituted NAD+?
▼
Yes, but temperature control is critical. Reconstituted NAD+ must remain at 2–8°C continuously. Use a medical-grade cooler designed for insulin or peptides — products like the FRIO wallet or a portable medical fridge maintain the required temperature range without electricity. Standard ice packs in a soft cooler are insufficient because they allow temperature fluctuations. If traveling by air, carry the vial in your carry-on luggage with a travel letter from your prescribing physician explaining the medical necessity.
What does ‘lyophilised’ mean in the context of NAD+ peptides?
▼
Lyophilisation is freeze-drying — a process that removes water from the NAD+ solution under vacuum at sub-zero temperatures, leaving behind a stable powder. This prevents the hydrolysis and oxidation reactions that degrade NAD+ in liquid form. Lyophilised NAD+ can be stored at −20°C for 12–24 months without significant potency loss. Reconstitution reverses the process by adding bacteriostatic water, but once rehydrated, the 14-day refrigerated stability window applies.
Is compounded NAD+ the same as pharmaceutical-grade NAD+?
▼
Compounded NAD+ is produced by FDA-registered 503B outsourcing facilities or state-licensed compounding pharmacies and contains the same active molecule as pharmaceutical-grade NAD+, but it does not undergo the full FDA approval process required for finished drug products. Compounding facilities follow USP (United States Pharmacopeia) sterility and purity standards, but batch-level oversight is less rigorous than FDA-approved pharmaceuticals. Compounded NAD+ is significantly less expensive and is the primary source for most therapeutic NAD+ protocols.
What should I do if I see particles in my reconstituted NAD+ solution?
▼
Discard the vial immediately. Visible particles indicate either incomplete dissolution, protein aggregation, or contamination. Properly reconstituted NAD+ should be completely clear with no cloudiness or floating material. Do not attempt to filter or use the solution — particulates can cause injection site reactions or embolism if injected. Contact your supplier for a replacement vial. Reputable compounding pharmacies will replace defective vials without charge.
Transforming Lives, One Step at a Time
Keep reading
Semaglutide Body Dysmorphia — Recognition & Management
Semaglutide body dysmorphia affects 15–30% of rapid weight loss patients. Recognize symptoms early and implement structured mental health support
Semaglutide 1 Month Weight Loss — What to Expect | TrimrX
Most patients lose 4–6 pounds in month one on semaglutide — appetite suppression starts within 72 hours, but meaningful fat loss requires 8–12 weeks at
Semaglutide Eating Disorders — Safety & Risk Profile
Semaglutide can trigger or worsen eating disorders through appetite suppression and delayed gastric emptying — screening before prescription is critical.